Alpha-1 Antitrypsin Deficiency: Bridging Care
Recognize the early signs of alpha-1 antitrypsin deficiency–associated liver disease (AATD) and develop effective therapeutic strategies and management with this accredited resource. Listen to the podcast series or watch a symposium from EASL 2025, hosted by Rohit Loomba, to earn CME credits.
EASL 2025 symposium (1 CME credit)
Watch Rohit Loomba and colleagues discuss how to recognize early signs of liver disease and ensure liver health in asymptomatic patients.
Developed by EPG Health. This content has been developed independently of the sponsor, Takeda, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.